Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov;29(11):2353–2357. doi: 10.3201/eid2911.230814

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.

PMC Copyright notice

Comparisons of cumulative percentages of persons with mpox treated with tecovirimat during 2-week intervals in study of racial and socioeconomic equity of tecovirimat treatment during 2022 mpox emergency, New York City, New York, USA. Percentages of mpox cases diagnosed during May 19–October 29, 2022, are indicated. Treated persons who had no prescription date (n = 22) were not counted. A) Percentages according to race/ethnicity. B) Percentages according to neighborhood poverty level, defined as: low poverty, <10% of neighborhood population; medium, 10%–19.9%; high, 20%–29.9%; and very high, >30%.